Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Denali Therapeutics (DNLI) Return on Invested Capital (2019 - 2023)

Denali Therapeutics has reported Return on Invested Capital over the past 5 years, most recently at 0.0% for Q4 2023.

  • Quarterly Return on Invested Capital changed 0.0% to 0.0% in Q4 2023 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2023, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Invested Capital was 0.0% for Q4 2023 at Denali Therapeutics, down from 0.0% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q4 2020 and troughed at 0.0% in Q1 2020.
  • The 5-year median for Return on Invested Capital is 0.0% (2019), against an average of 0.0%.
  • Year-over-year, Return on Invested Capital changed 0bps in 2020 and then rose 1bps in 2021.
  • A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2019, then surged by 135bps to 0.0% in 2020, then tumbled by -590bps to 0.0% in 2021, then fell by -22bps to 0.0% in 2022, then soared by 50bps to 0.0% in 2023.
  • Per Business Quant, the three most recent readings for DNLI's Return on Invested Capital are 0.0% (Q4 2023), 0.0% (Q3 2023), and 0.0% (Q2 2023).